WASHINGTON, DC – House Energy and Commerce Committee leaders today wrote to Environmental Protection Agency Administrator Gina McCarthy to follow up on the committee’s request for documents and information relating to the agency’s consideration of carbon capture technologies in developing its greenhouse gas emissions standards for new power plants.
WASHINGTON, DC – House Energy and Commerce Committee leaders today sent letters to the Centers for Disease Control and Prevention and the Inspector General of the Department of Health and Human Services regarding the recent anthrax exposure at the CDC in Atlanta. The Subcommittee on Oversight and Investigations will hold a hearing to review the incident next Wednesday, July 16, at 10 a.m.
The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), has scheduled a hearing for Wednesday, July 16, 2014, at 10:15 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled “Failure to Verify: Concerns Regarding PPACA’s Eligibility System.” Representatives from the Department of Health and Human Services Office of the Inspector General (HHS OIG) will testify.
WASHINGTON, DC – The Energy and Commerce Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), today held a hearing in the 21st Century Cures initiative to discuss opportunities to modernize clinical trials in the effort to accelerate the discovery, development, and delivery cycle of new cures and treatments. Witnesses spoke about how advances in technology, data analysis, and personalized medicine can strengthen clinical trials, safely bringing more effective drugs and devices to patients more quickly and at lower costs.
WASHINGTON, DC – The House of Representatives on Tuesday approved H.R. 1528, the Veterinary Medicine Mobility Act, by a voice vote. The Energy and Commerce Committee approved this bipartisan legislation, authored by Rep. Kurt Schrader (D-OR), in April.
The Subcommittee on Oversight and Investigations, chaired by Rep. Tim Murphy (R-PA), has scheduled a hearing for Wednesday, July 16, 2014, at 10 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled “Review of CDC Anthrax Lab Incident.” Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention (CDC), will be among the witnesses testifying.